Iterative Scopes, a specialist in the development of precision-based gastrointestinal (GI) disease technologies and software, has raised USD150 million in Series B financing to accelerate development of its core algorithmic innovations that are designed to transform gastroenterology care for patients.
The round was co-led by Insight Partners and Clearlake Capital Group, as well as returning investors Obvious Ventures, Johnson and Johnson Innovation-JJDC Inc, Eli Lilly, Breyer Capital and other industry and financial leaders.
The latest financing comes shortly after the company raised USD30 million in a Series A round in August 2021 which brings the total raised in 2021 to USD182 million.
